[{"Assets_0_Q2_USD":146093000.0,"CommonStockSharesOutstanding_0_Q2_shares":69913410.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-44181000.0,"NetIncomeLoss_1_Q2_USD":-10759000.0,"NetIncomeLoss_2_Q2_USD":-35092000.0,"StockholdersEquity_0_Q2_USD":-17968000.0,"Ticker":"MCRB","CIK":"1609809","name":"SERES THERAPEUTICS, INC.","OfficialName":"Seres Therapeutics Inc. Common Stock","form":"10-Q","period":"20190630","fy":"2019.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"533683334.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20190806"}]